XML 69 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (67,316) $ (110,731)
Adjustments to reconcile net loss to net cash, cash equivalents and restricted cash used in operating activities:    
Loss on issuance of warrants 0 47,920
Loss on issuance of Purchase Rights 674 0
Change in fair value of warrants 7,755 0
Change in fair value of Purchase Rights 19,617 0
Change in fair value of Series D 2X liquidation preference 0 130
Stock-based compensation 6,740 16,086
Depreciation 198 196
Noncash lease expenses 487 0
Changes in operating assets and liabilities:    
Prepaid and other assets (408) (207)
Accounts payable (3,628) (1,501)
Accrued expenses and other liabilities (5,186) 2,139
Accrued compensation (8) (56)
Operating lease liabilities (576) 0
Deferred rent, net of current portion 0 (229)
Net cash, cash equivalents and restricted cash used in operating activities (41,651) (46,253)
Cash flows from investing activities:    
Purchases of property and equipment (23) 0
Proceeds from sale of Softcup line of business 250 250
Purchase of short-term investments (3,715) 0
Cash acquired in connection with the Merger 0 1,900
Net cash, cash equivalents and restricted cash (used in) provided by investing activities (3,488) 2,150
Cash flows from financing activities:    
Proceeds from issuance of common stock- exercise of warrants 6,273 0
Proceeds from issuance of common stock, warrants and Purchase Rights in connection with Private Placement, net of financial advisory fees 75,400 20,000
Proceeds from issuance of common stock, pre-funded warrants and common warrants in connection with the Offering, net of underwriting discounts and commissions 0 37,542
Proceeds from issuance of common stock - exercise of stock options 46 42
Repayment of Note Payable (4,010) 0
Payment of cash dividends for Series D redeemable convertible preferred stock 0 (157)
Cash paid for financing costs (1,180) (977)
Payments of tax withholdings related to vesting of restricted stock awards (645) (1,526)
Net cash, cash equivalents and restricted cash provided by financing activities 75,884 54,924
Net change in cash, cash equivalents and restricted cash 30,745 10,821
Cash, cash equivalents and restricted cash, beginning of period 1,761 1,701
Cash, cash equivalents and restricted cash, end of period 32,506 12,522
Supplemental disclosure of noncash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 802 0
Financing costs included in accounts payable and accrued expenses 50 536
Purchases of property and equipment included in accounts payable and accrued expenses 127 0
Reclassification of warrants and Purchase Rights liability to equity 6,120 0
Net assets acquired in connection with the Merger 0 46
Convertible Preferred Stock    
Supplemental disclosure of noncash investing and financing activities:    
Conversion of preferred stock 0 121,315
Series D Redeemable Convertible Preferred Stock    
Supplemental disclosure of noncash investing and financing activities:    
Conversion of preferred stock 0 68,622
Series D 2X Liquidation Preference Liability    
Supplemental disclosure of noncash investing and financing activities:    
Conversion of preferred stock $ 0 $ 80,000